NCT04666103

Brief Summary

Recent trends in the management of patients with low-risk papillary thyroid carcinoma who have a nonsuspicious or cytologically benign contralateral nodule call into question the need for routine total thyroidectomy. Although the lobectomy for the unilateral thyroid cancer with contralateral benign nodules is sufficient treatment, some of the patients might suffer from the anxiety of the residual benign thyroid nodule and tend to choose total thyroidectomy, which might be overtreatment. Thermal ablation has been proven to be effective in achieving nodule shrinkage and being also free from major complications. In our institution, intraoperative RFA was a proposed alternative strategy to treat the contralateral benign nodules after the thyroid lobectomy for the malignant lobe, which was found to have a better quality of life on anxiety, physiological health, social family, psychological and sensory mentions with a considerable complication rate.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,264

participants targeted

Target at P75+ for not_applicable

Timeline
7mo left

Started Dec 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Dec 2020Dec 2026

First Submitted

Initial submission to the registry

December 7, 2020

Completed
4 days until next milestone

Study Start

First participant enrolled

December 11, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 14, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 12, 2026

Expected
Last Updated

December 14, 2020

Status Verified

December 1, 2020

Enrollment Period

1.1 years

First QC Date

December 7, 2020

Last Update Submit

December 11, 2020

Conditions

Outcome Measures

Primary Outcomes (5)

  • Rate of complications

    Transient or persistent hypoparathyroidism confirmed by serum calcium levels was less than the lower limit at examination center and had symptoms of hypocalcemia. Postoperative vocal cord paralysis was defined as fixed vocal cord mobility with laryngofiberoscopic examination.

    Up to 2 years

  • Scores of hospital anxiety and depression scale (HADS)

    All patients were requested to answer the HADS questionnaire, the scores of which were recorded.

    Up to 6 months

  • Scores of fear of progression questionnaire-short form(FPQS)

    All patients were requested to answer the FPQS questionnaire, the scores of which were recorded.

    Up to 6 months

  • Scores of thyroid cancer- specific quality of life (THYCA-QoL) questionnaire

    All patients were requested to answer the THYCA-QoL questionnaire, the scores of which were recorded.

    Up to 6 months

  • Rate of recurrence

    Lymph node recurrence or distant recurrence

    5-year estimate reported after a median follow-up of 60 months

Study Arms (2)

Thyroid lobectomy with intraoperative thermal ablation

EXPERIMENTAL

Thyroid lobectomy was performed with a standard technique of fine capsular en bloc dissection and resection, from inferior pole to superior pole. Superior parathyroid glands were identified and preserved in situ, inferior parathyroid glands were protected in situ or autotransplanted in the sternocleidomastoid muscle according to three certain types based on their blood supply and location. All the patients underwent lobectomy received ipsilateral therapic central compartment neck dissection. After the thyroid lobectomy, the contralateral benign thyroid nodule was treated with intraoperative thermal ablation. The "hydrodissection technique" was used during the ablation process to prevent recurrent laryngeal nerve, esophageal and other important structures from being destroyed by heat energy.

Procedure: Intraoperative thermal ablation

Thyroid lobectomy

NO INTERVENTION

Thyroid lobectomy was performed with a standard technique of fine capsular en bloc dissection and resection, from inferior pole to superior pole. Superior parathyroid glands were identified and preserved in situ, inferior parathyroid glands were protected in situ or autotransplanted in the sternocleidomastoid muscle according to three certain types based on their blood supply and location. All the patients underwent lobectomy received ipsilateral therapic central compartment neck dissection.

Interventions

After the thyroid lobectomy, the contralateral benign thyroid nodule was treated with intraoperative thermal ablation. The "hydrodissection technique'' was used during the ablation process to prevent recurrent laryngeal nerve, esophageal and other important structures from being destroyed by heat energy.

Thyroid lobectomy with intraoperative thermal ablation

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients diagnosed with unilateral thyroid carcinoma and contralateral benign nodule confirmed by preoperative ultrasound-guided fine-needle aspiration cytology;
  • Patients with contralateral nodules ≤ 20mm and located in the thyroid gland;
  • Patients with clinical node-negative cervical compartment at palpation and neck ultrasound.

You may not qualify if:

  • Previous history of neck surgery
  • Previous history of neck radiation therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhongnan Hospital of Wuhan University

Wuhan, Hubei, 430071, China

RECRUITING

MeSH Terms

Conditions

Thyroid NeoplasmsThyroid Nodule

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsEndocrine System DiseasesThyroid Diseases

Study Officials

  • Gaosong Wu, Ph.D.

    Department of Breast and Thyroid Surgery, Zhongnan Hospital of Wuhan University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Qianqian Yuan, M.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

December 7, 2020

First Posted

December 14, 2020

Study Start

December 11, 2020

Primary Completion

December 31, 2021

Study Completion (Estimated)

December 12, 2026

Last Updated

December 14, 2020

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share

Locations